

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 54.60 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 69.42 | Oscillator | Neutral |
| Williams %R (14) | -35.28 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.73 (Hist 0.98) | Oscillator | Strong Buy |
| Average Directional Index (14) | 14.07 (+DI 18.0 / -DI 15.5) | Trend | Neutral |
| EMA 20 | 87.37 | MA | Buy |
| SMA 20 | 85.40 | MA | Strong Buy |
| EMA 50 | 88.55 | MA | Buy |
| SMA 50 | 88.52 | MA | Buy |
| SMA 200 | 63.38 | MA | Strong Buy |
Current price $89.71
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Sep 15, 26 | Bernstein | upgrade | Market Perform | Outperform |
| Aug 24, 26 | JP Morgan | maintain | Underweight | Underweight |
| Aug 11, 26 | Citigroup | upgrade | Sell | Neutral |
| Aug 11, 26 | Wells Fargo | maintain | Overweight | Overweight |
| Aug 6, 26 | Barclays | maintain | Equal Weight | Equal Weight |
| Aug 6, 26 | Evercore ISI Group | maintain | In Line | In Line |
| Aug 6, 26 | Benchmark | maintain | Buy | Buy |
| Aug 6, 26 | Truist Securities | maintain | Hold | Hold |
| Jul 23, 26 | Citigroup | downgrade | Neutral | Sell |
TTM vs. 5-year historical average (annual ratios)
| Metric | AGL | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -5.8x | -22.0x · sector 20.7x | Discount |
| Forward P/E (FY26E) | -38.6x | EPS est. -2.33 | Elevated |
| Price / Book | 6.6x | 5.4x | Elevated |
| Price / Sales | 0.3x | 2.1x | Discount |
| EV / EBITDA | -6.1x | -28.8x | Discount |
| Return on equity | -119.3% | — | Weak |
| Gross margin | 0.0% | 1.5% | Below hist. |
| Debt / Equity | 0.15 | 0.11 | Conservative |
| Piotroski / Altman Z | 3/9 | Z 2.24 | Grey zone |
Discounted cash flow model
FY2025 · 10-K disclosure
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Aug 16, 26 | Gertsch Timothy | officer: Chief Accounting Officer | F-InKind | 17 @ $96.90 | $1.65K |
Stock news · updated daily
Here is how Agilon Health (AGL) and Arcturus Therapeutics (ARCT) have performed compared to their sector so far this year.
Fulgent Genetics (NASDAQ: FLGT - Get Free Report) and Agilon Health (NYSE: AGL - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk and profitability. Valuation and Earnings This table compares Fulgent
| Aug 1, 26 |
| Zamore Denise |
| officer: Chief Legal Officer |
| F-InKind |
| 37 @ $91.61 |
| $3.39K |
| Jul 1, 26 | Schwaneke Jeffrey A. | officer: Chief Financial Officer | F-InKind | 2,311 @ $111.74 | $258.2K |
| Jun 1, 26 | Zamore Denise | officer: Chief Legal Officer | F-InKind | 485 @ $92.54 | $44.88K |
| Jun 2, 26 | Wulf John William | director | A-Award | 2,133 | — |
| Jun 2, 26 | Williams Ronald A | director | A-Award | 2,133 | — |
| Jun 2, 26 | Mcloughlin Karen | director | A-Award | 2,133 | — |
| Jun 2, 26 | Mckenzie Diana | director | A-Award | 2,133 | — |
Corebridge Financial today announced the launch of Progressive Trigger, a first-of-its-kind index annuity interest-crediting strategy designed to help customers
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | 0.14 | 1.04 | Beat 622.2% | $1.49B |
| May 6, 2026 | 1.13 | 1.80 | Beat 59.3% | $1.42B |
| Feb 25, 2026 | -6.75 | -11.50 | Miss -70.4% | $1.57B |
| Nov 4, 2025 | -3.73 | -6.75 | Miss -80.7% | $1.44B |
| Aug 5, 2025 | -2.75 | -6.25 | Miss -127.3% | $1.39B |
| May 6, 2025 | -0.07 | 0.73 | Beat 1082.4% | $1.53B |
| 8-K | Aug 5, 2026 | 2026-08-05 16:07:17 | View |
| 4 | Aug 4, 2026 | 2026-08-04 16:23:22 | View |
| 8-K | Jul 22, 2026 | 2026-07-21 17:51:52 | View |
| 4 | Jul 2, 2026 | 2026-07-02 18:44:23 | View |
| 4 | Jun 5, 2026 | 2026-06-05 19:46:43 | View |
| 4 | Jun 4, 2026 | 2026-06-04 21:57:15 | View |
Proxy statement (DEF 14A) disclosures